Lightship Partners with Castor to Scale Virtual Trials
Lightship and Castor have announced a strategic partnership to run direct-to-patient (hybrid) clinical trials at scale.
For decades, clinical trials have experienced low rates of participation relative to the distribution of a condition, which can impact the ability to access diverse patient populations and construct a representative sample. One of the main reasons for this is the high burden of participation that patients often experience. Lightship’s delivery model combined with an in-house care team will provide the patient experience in clinical trials partnering with Castor’s globally compliant Decentralized Clinical Trial and Clinical Data Management platform.
For more information, click here.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.
